DIMINISHED TOXICITY OF METHOTREXATE IN CD2F1 MICE PRETREATED WITH CYCLOHEXIMIDEPANASCI L; POLIZZI G; PALMER S et al.1982; CANCER LETT.; ISSN 0304-3835; NLD; DA. 1982; VOL. 15; NO 1; PP. 81-86; BIBL. 7 REF.Article

Effect of ERCC-1 overexpression on sensitivity of Chinese hamster ovary cells to DNA damaging agentsBRAMSON, J; PANASCI, L. C.Cancer research (Baltimore). 1993, Vol 53, Num 14, pp 3237-3240, issn 0008-5472Article

Mechanism of decrease of protein synthesis by sodium cyanate in murine P388 leukemia cellsLAZARUS, P; PANASCI, L. C.Cancer research (Baltimore). 1987, Vol 47, Num 19, pp 5102-5107, issn 0008-5472Article

Potentiation of chloroambucil toxicity in B-CLL lymphocytes using the DNA synthesis inhibitors aphidicolin and 1-β-D-arabinofuranosylcytosineBRAMSON, J; PANASCI, L.Biochemical pharmacology. 1995, Vol 50, Num 1, pp 131-135, issn 0006-2952Article

Further studies on amino acid transport in murine P388 leukemia cells in vitro: presence of system y⁺LAZARUS, P; PANASCI, L. C.Biochimica et biophysica acta. 1987, Vol 898, Num 2, pp 154-158, issn 0006-3002Article

Characterization of L-threonine and L-glutamine transport in murine P388 leukemia cells in vitro. Presence of an N-like amino acid transport systemLAZARUS, P; PANASCI, L. C.Biochimica et biophysica acta. 1986, Vol 856, Num 3, pp 488-495, issn 0006-3002Article

Effect of alkyl-N-purine DNA glycosylase overexpression on cellular resistance to bifunctional alkylating agentsBRAMSON, J; O'CONNOR, T; PANASCI, L et al.Biochemical pharmacology. 1995, Vol 50, Num 1, pp 39-44, issn 0006-2952Article

Transport of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in the human glioma cell line SK-MG-1 is mediated by an epinephrine-sensitive carrier systemNOE, A. J; MALAPETSA, A; PANASCI, L. C et al.Molecular pharmacology. 1993, Vol 44, Num 1, pp 204-209, issn 0026-895XArticle

The cytotoxicity of a 2-chloroethylnitrosourea analog of sarcosinamide in the SK-MG-1 human glioma cell line as a possible indicator for transportSKALSKI, V; FEINDEL, W; PANASCI, L. C et al.Journal of neuro-oncology. 1989, Vol 7, Num 2, pp 189-193, issn 0167-594X, 5 p.Article

PHASE I TRIAL OF CHLOROZOTOCIN: ATTEMPTED AMELIORATION OF MYELOTOXICITY BY GLUCOSE ADMINISTRATIONPANASCI L; COMIS R; GINSBERG S et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 7-8; PP. 647-650; BIBL. 12 REF.Article

SYSTEMIC CHEMOTHERAPY FOR A PRIMARY GERM CELL TUMOR OF THE BRAIN: A PHARMACOKINETIC STUDYGINSBERG S; KIRSHNER J; REICH S et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 5-6; PP. 477-483; BIBL. 23 REF.Article

DNA repair enzyme expression in chronic lymphocytic leukemia vis-à-vis nitrogen mustard drug resistanceBRAMSON, J; MCQUILLAN, A; PANASCI, L. C et al.Cancer letters. 1995, Vol 90, Num 2, pp 139-148, issn 0304-3835Article

DNA-dependent protein kinase activity correlates with clinical and in vitro sensitivity of chronic lymphocytic leukemia lymphocytes to nitrogen mustardsMULLER, C; CHRISTODOULOPOULOS, G; SALLES, B et al.Blood. 1998, Vol 92, Num 7, pp 2213-2219, issn 0006-4971Article

Altered cytotoxicity of (2-chloroethyl)-3-sarcosinamide-1-nitrosourea in human glioma cell lines SK-MG-1 and SKI-1 correlates with differential transport kineticsNOË, A. J; MALAPETSA, A; PANASCI, L. C et al.Cancer research (Baltimore). 1994, Vol 54, Num 6, pp 1491-1496, issn 0008-5472Article

Transport of amino acid amide sarcosinamide and sarcosinamide chloroethylnitrosourea in human glioma SK-MG-1 cellsSKALSKI, V; FEINDEL, W; PANASCI, L. C et al.Cancer research (Baltimore). 1990, Vol 50, Num 10, pp 3062-3066, issn 0008-5472, 5 p.Article

Evidence for increased αMSH receptor binding in the F₁ variant of B₁₆ melanoma cells grown in dialyzed fetal calf serumMCQUILLAN, A; HUTCHINSON, M; PANASCI, L. C et al.Journal of cellular physiology. 1989, Vol 141, Num 2, pp 281-283, issn 0021-9541, 3 p.Article

A phase II study of sequential methotrexate and fluorouracil in advanced colorectal cancerPANASCI, L; FORD, J; MARGOLESE, R et al.Cancer chemotherapy and pharmacology. 1985, Vol 15, Num 2, pp 164-166, issn 0344-5704Article

The effect of prolonged incubations and heat denaturation on melphalan-induced DNA cross-links as measured by the ethidium bromide fluorescence assayPANASCI, L; MCQUILLAN, A; COHEN, J et al.Cancer letters. 1990, Vol 50, Num 2, pp 129-132, issn 0304-3835, 4 p.Article

The cytolytic effect of L-2,4 diaminobutyric acid with malignant glioma cells and fibroblastsPANASCI, L; MCQUILLAN, A; FEINDEL, W et al.Cancer chemotherapy and pharmacology. 1988, Vol 21, Num 2, pp 143-144, issn 0344-5704Article

SarCNU (2-chloroethyl-3-sarcosinamide-1-nitrosourea) : a novel analogue of chloroethylnitrosourea that is transported by the catecholamine uptake₂ carrier, which mediates increased cytotoxityPANASCI, L. C; MARCANTONIO, D; NOË, A. J et al.Cancer chemotherapy and pharmacology. 1996, Vol 37, Num 6, pp 505-508, issn 0344-5704Article

Correlation between the cytotoxicity of melphalan and DNA crosslinks as detected by the ethidium bromide fluorescence assay in the F₁ variant of B₁₆ melanoma cellsGARCIA, S. T; MCQUILLAN, A; PANASCI, L et al.Biochemical pharmacology. 1988, Vol 37, Num 16, pp 3189-3192, issn 0006-2952Article

Biological activity, binding, and metabolic fate of Ac-[Nle⁴, D-Phe⁷]α-MSH_4-11NH₂ with the F₁ variant of B₁₆ melanoma cellsPANASCI, L. C; MCQUILLAN, A; KAUFMAN, M et al.Journal of cellular physiology. 1987, Vol 132, Num 1, pp 97-103, issn 0021-9541Article

Alternating combination chemotherapy using cisplatin-bleomycin with sequential methotrexate-5-FU plus leucovorin rescue in patients with head and neck cancerPANASCI, L; GRAVENOR, D; BLACK, M et al.Cancer treatment reports. 1985, Vol 69, Num 9, pp 1015-1017, issn 0361-5960Article

Correlation of resistance to nitrogen mustards in chronic lymphocytic leukemia with enhanced removal of melphalan-induced DNA cross-linksTORRES-GARCIA, S. J; COUSINEAU, L; CAPLAN, S et al.Biochemical pharmacology. 1989, Vol 38, Num 18, pp 3122-3123, issn 0006-2952Article

Chemotherapy for advanced pancreatic cancer: a comparison of 5-fluorouracil, adriamycin, and mitomycin (FAM) with 5-fluorouracil, streptozotocin, and mitomycin (FSM)OSTER, M. W; GRAY, R; PANASCI, L et al.Cancer. 1986, Vol 57, Num 1, pp 29-33, issn 0008-543XArticle